世界の栄養障害型表皮水疱症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dystrophic Epidermolysis Bullosa Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4167
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、栄養障害型表皮水疱症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、コルチコステロイド、オピオイド鎮痛薬、抗けいれん薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・栄養障害型表皮水疱症治療の市場動向
・企業の競争状況、市場シェア
・栄養障害型表皮水疱症治療の種類別市場規模と予測2016-2027（抗生物質、コルチコステロイド、オピオイド鎮痛薬、抗けいれん薬、その他）
・栄養障害型表皮水疱症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、その他）
・栄養障害型表皮水疱症治療の北米市場規模2016-2027（アメリカ、カナダ）
・栄養障害型表皮水疱症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・栄養障害型表皮水疱症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・栄養障害型表皮水疱症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・栄養障害型表皮水疱症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Krystal Biotech、Castle Creek Biosciences、Abeona Therapeutics、Amryt Pharma、Wings Therapeutics、Phoenix Tissue Repair、InMed Pharmaceuticals、RegeneRx、Holostem Terapie Avanzate）
・結論

Market Analysis and Insights: Global Dystrophic Epidermolysis Bullosa Treatment Market
The global Dystrophic Epidermolysis Bullosa Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dystrophic Epidermolysis Bullosa Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dystrophic Epidermolysis Bullosa Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dystrophic Epidermolysis Bullosa Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dystrophic Epidermolysis Bullosa Treatment market.

Global Dystrophic Epidermolysis Bullosa Treatment Scope and Market Size
Dystrophic Epidermolysis Bullosa Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dystrophic Epidermolysis Bullosa Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Corticosteroids
Opioid Analgesics
Anticonvulsant
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Krystal Biotech
Castle Creek Biosciences
Abeona Therapeutics
Amryt Pharma
Wings Therapeutics
Phoenix Tissue Repair
InMed Pharmaceuticals
RegeneRx
Holostem Terapie Avanzate

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dystrophic Epidermolysis Bullosa Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Corticosteroids
1.2.4 Opioid Analgesics
1.2.5 Anticonvulsant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dystrophic Epidermolysis Bullosa Treatment Market Perspective (2016-2027)
2.2 Dystrophic Epidermolysis Bullosa Treatment Growth Trends by Regions
2.2.1 Dystrophic Epidermolysis Bullosa Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dystrophic Epidermolysis Bullosa Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dystrophic Epidermolysis Bullosa Treatment Industry Dynamic
2.3.1 Dystrophic Epidermolysis Bullosa Treatment Market Trends
2.3.2 Dystrophic Epidermolysis Bullosa Treatment Market Drivers
2.3.3 Dystrophic Epidermolysis Bullosa Treatment Market Challenges
2.3.4 Dystrophic Epidermolysis Bullosa Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dystrophic Epidermolysis Bullosa Treatment Players by Revenue
3.1.1 Global Top Dystrophic Epidermolysis Bullosa Treatment Players by Revenue (2016-2021)
3.1.2 Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dystrophic Epidermolysis Bullosa Treatment Revenue
3.4 Global Dystrophic Epidermolysis Bullosa Treatment Market Concentration Ratio
3.4.1 Global Dystrophic Epidermolysis Bullosa Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dystrophic Epidermolysis Bullosa Treatment Revenue in 2020
3.5 Dystrophic Epidermolysis Bullosa Treatment Key Players Head office and Area Served
3.6 Key Players Dystrophic Epidermolysis Bullosa Treatment Product Solution and Service
3.7 Date of Enter into Dystrophic Epidermolysis Bullosa Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dystrophic Epidermolysis Bullosa Treatment Breakdown Data by Type
4.1 Global Dystrophic Epidermolysis Bullosa Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Type (2022-2027)

5 Dystrophic Epidermolysis Bullosa Treatment Breakdown Data by Application
5.1 Global Dystrophic Epidermolysis Bullosa Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dystrophic Epidermolysis Bullosa Treatment Market Size (2016-2027)
6.2 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type
6.2.1 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021)
6.2.2 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027)
6.2.3 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2027)
6.3 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application
6.3.1 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021)
6.3.2 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027)
6.3.3 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2027)
6.4 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country
6.4.1 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021)
6.4.2 North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size (2016-2027)
7.2 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type
7.2.1 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2027)
7.3 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application
7.3.1 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2027)
7.4 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Country
7.4.1 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type
8.2.1 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application
8.3.1 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Region
8.4.1 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size (2016-2027)
9.2 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type
9.2.1 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2027)
9.3 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application
9.3.1 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2027)
9.4 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country
9.4.1 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type
10.2.1 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application
10.3.1 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Country
10.4.1 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Krystal Biotech
11.1.1 Krystal Biotech Company Details
11.1.2 Krystal Biotech Business Overview
11.1.3 Krystal Biotech Dystrophic Epidermolysis Bullosa Treatment Introduction
11.1.4 Krystal Biotech Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.1.5 Krystal Biotech Recent Development
11.2 Castle Creek Biosciences
11.2.1 Castle Creek Biosciences Company Details
11.2.2 Castle Creek Biosciences Business Overview
11.2.3 Castle Creek Biosciences Dystrophic Epidermolysis Bullosa Treatment Introduction
11.2.4 Castle Creek Biosciences Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.2.5 Castle Creek Biosciences Recent Development
11.3 Abeona Therapeutics
11.3.1 Abeona Therapeutics Company Details
11.3.2 Abeona Therapeutics Business Overview
11.3.3 Abeona Therapeutics Dystrophic Epidermolysis Bullosa Treatment Introduction
11.3.4 Abeona Therapeutics Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.3.5 Abeona Therapeutics Recent Development
11.4 Amryt Pharma
11.4.1 Amryt Pharma Company Details
11.4.2 Amryt Pharma Business Overview
11.4.3 Amryt Pharma Dystrophic Epidermolysis Bullosa Treatment Introduction
11.4.4 Amryt Pharma Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.4.5 Amryt Pharma Recent Development
11.5 Wings Therapeutics
11.5.1 Wings Therapeutics Company Details
11.5.2 Wings Therapeutics Business Overview
11.5.3 Wings Therapeutics Dystrophic Epidermolysis Bullosa Treatment Introduction
11.5.4 Wings Therapeutics Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.5.5 Wings Therapeutics Recent Development
11.6 Phoenix Tissue Repair
11.6.1 Phoenix Tissue Repair Company Details
11.6.2 Phoenix Tissue Repair Business Overview
11.6.3 Phoenix Tissue Repair Dystrophic Epidermolysis Bullosa Treatment Introduction
11.6.4 Phoenix Tissue Repair Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.6.5 Phoenix Tissue Repair Recent Development
11.7 InMed Pharmaceuticals
11.7.1 InMed Pharmaceuticals Company Details
11.7.2 InMed Pharmaceuticals Business Overview
11.7.3 InMed Pharmaceuticals Dystrophic Epidermolysis Bullosa Treatment Introduction
11.7.4 InMed Pharmaceuticals Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.7.5 InMed Pharmaceuticals Recent Development
11.8 RegeneRx
11.8.1 RegeneRx Company Details
11.8.2 RegeneRx Business Overview
11.8.3 RegeneRx Dystrophic Epidermolysis Bullosa Treatment Introduction
11.8.4 RegeneRx Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.8.5 RegeneRx Recent Development
11.9 Holostem Terapie Avanzate
11.9.1 Holostem Terapie Avanzate Company Details
11.9.2 Holostem Terapie Avanzate Business Overview
11.9.3 Holostem Terapie Avanzate Dystrophic Epidermolysis Bullosa Treatment Introduction
11.9.4 Holostem Terapie Avanzate Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
11.9.5 Holostem Terapie Avanzate Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dystrophic Epidermolysis Bullosa Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Opioid Analgesics
Table 5. Key Players of Anticonvulsant
Table 6. Key Players of Others
Table 7. Global Dystrophic Epidermolysis Bullosa Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Dystrophic Epidermolysis Bullosa Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Dystrophic Epidermolysis Bullosa Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Regions (2016-2021)
Table 11. Global Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Regions (2022-2027)
Table 13. Dystrophic Epidermolysis Bullosa Treatment Market Trends
Table 14. Dystrophic Epidermolysis Bullosa Treatment Market Drivers
Table 15. Dystrophic Epidermolysis Bullosa Treatment Market Challenges
Table 16. Dystrophic Epidermolysis Bullosa Treatment Market Restraints
Table 17. Global Dystrophic Epidermolysis Bullosa Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Players (2016-2021)
Table 19. Global Top Dystrophic Epidermolysis Bullosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dystrophic Epidermolysis Bullosa Treatment as of 2020)
Table 20. Ranking of Global Top Dystrophic Epidermolysis Bullosa Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Dystrophic Epidermolysis Bullosa Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Dystrophic Epidermolysis Bullosa Treatment Product Solution and Service
Table 24. Date of Enter into Dystrophic Epidermolysis Bullosa Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Dystrophic Epidermolysis Bullosa Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Dystrophic Epidermolysis Bullosa Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Krystal Biotech Company Details
Table 65. Krystal Biotech Business Overview
Table 66. Krystal Biotech Dystrophic Epidermolysis Bullosa Treatment Product
Table 67. Krystal Biotech Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 68. Krystal Biotech Recent Development
Table 69. Castle Creek Biosciences Company Details
Table 70. Castle Creek Biosciences Business Overview
Table 71. Castle Creek Biosciences Dystrophic Epidermolysis Bullosa Treatment Product
Table 72. Castle Creek Biosciences Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 73. Castle Creek Biosciences Recent Development
Table 74. Abeona Therapeutics Company Details
Table 75. Abeona Therapeutics Business Overview
Table 76. Abeona Therapeutics Dystrophic Epidermolysis Bullosa Treatment Product
Table 77. Abeona Therapeutics Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 78. Abeona Therapeutics Recent Development
Table 79. Amryt Pharma Company Details
Table 80. Amryt Pharma Business Overview
Table 81. Amryt Pharma Dystrophic Epidermolysis Bullosa Treatment Product
Table 82. Amryt Pharma Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 83. Amryt Pharma Recent Development
Table 84. Wings Therapeutics Company Details
Table 85. Wings Therapeutics Business Overview
Table 86. Wings Therapeutics Dystrophic Epidermolysis Bullosa Treatment Product
Table 87. Wings Therapeutics Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 88. Wings Therapeutics Recent Development
Table 89. Phoenix Tissue Repair Company Details
Table 90. Phoenix Tissue Repair Business Overview
Table 91. Phoenix Tissue Repair Dystrophic Epidermolysis Bullosa Treatment Product
Table 92. Phoenix Tissue Repair Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 93. Phoenix Tissue Repair Recent Development
Table 94. InMed Pharmaceuticals Company Details
Table 95. InMed Pharmaceuticals Business Overview
Table 96. InMed Pharmaceuticals Dystrophic Epidermolysis Bullosa Treatment Product
Table 97. InMed Pharmaceuticals Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 98. InMed Pharmaceuticals Recent Development
Table 99. RegeneRx Company Details
Table 100. RegeneRx Business Overview
Table 101. RegeneRx Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 102. RegeneRx Recent Development
Table 103. Holostem Terapie Avanzate Company Details
Table 104. Holostem Terapie Avanzate Business Overview
Table 105. Holostem Terapie Avanzate Dystrophic Epidermolysis Bullosa Treatment Product
Table 106. Holostem Terapie Avanzate Revenue in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021) & (US$ Million)
Table 107. Holostem Terapie Avanzate Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Corticosteroids Features
Figure 4. Opioid Analgesics Features
Figure 5. Anticonvulsant Features
Figure 6. Others Features
Figure 7. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Dystrophic Epidermolysis Bullosa Treatment Report Years Considered
Figure 12. Global Dystrophic Epidermolysis Bullosa Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Dystrophic Epidermolysis Bullosa Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Regions (2022-2027)
Figure 16. Global Dystrophic Epidermolysis Bullosa Treatment Market Share by Players in 2020
Figure 17. Global Top Dystrophic Epidermolysis Bullosa Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dystrophic Epidermolysis Bullosa Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Dystrophic Epidermolysis Bullosa Treatment Revenue in 2020
Figure 19. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Dystrophic Epidermolysis Bullosa Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Dystrophic Epidermolysis Bullosa Treatment Market Share by Type (2016-2027)
Figure 23. North America Dystrophic Epidermolysis Bullosa Treatment Market Share by Application (2016-2027)
Figure 24. North America Dystrophic Epidermolysis Bullosa Treatment Market Share by Country (2016-2027)
Figure 25. United States Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Dystrophic Epidermolysis Bullosa Treatment Market Share by Type (2016-2027)
Figure 29. Europe Dystrophic Epidermolysis Bullosa Treatment Market Share by Application (2016-2027)
Figure 30. Europe Dystrophic Epidermolysis Bullosa Treatment Market Share by Country (2016-2027)
Figure 31. Germany Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Dystrophic Epidermolysis Bullosa Treatment Market Share by Region (2016-2027)
Figure 41. China Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Dystrophic Epidermolysis Bullosa Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Dystrophic Epidermolysis Bullosa Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Dystrophic Epidermolysis Bullosa Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Krystal Biotech Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 61. Castle Creek Biosciences Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 62. Abeona Therapeutics Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 63. Amryt Pharma Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 64. Wings Therapeutics Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 65. Phoenix Tissue Repair Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 66. InMed Pharmaceuticals Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 67. RegeneRx Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 68. Holostem Terapie Avanzate Revenue Growth Rate in Dystrophic Epidermolysis Bullosa Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の表皮水疱症治療薬市場規模・現状・予測（2021年-2027年）

Global Epidermolysis Bullosa Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4195 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、表皮水疱症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EB-201、FCX-007、ICX-RHY、INM-750、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の表皮水疱症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Epidermolysis Bullosa Therapeutics Market The global Epidermolysis Bullosa Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年） In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment…
世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年） Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body a…
世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年） Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for …
世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年） Retroperitoneal fibrosis is the rare disease also known as Ormond’s disease. Retroperitoneal fibrosis is characterized by the inflammatory disorder in which abnormal formation of tissue or fibrosis occurs in the back of the abdominal cavity and behind the retro membrane. This area is known as retrop…